Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| COMPASS PATHWAYS | 3 | 11 | -4,48 % | ||
| DISC MEDICINE | 3 | 7 | -21,67 % | ||
| BIONTECH | 2 | 13 | -0,28 % | ||
| HALOZYME THERAPEUTICS | 2 | 6 | -0,15 % | ||
| MODERNA | 1 | 16 | +0,06 % | ||
| BIOMARIN PHARMACEUTICAL | 1 | 12 | -0,67 % | ||
| SUMMIT THERAPEUTICS | 1 | 12 | +2,26 % | ||
| VERA THERAPEUTICS | 1 | 9 | -0,12 % | ||
| PTC THERAPEUTICS | 1 | 4 | +0,85 % | ||
| SPYRE THERAPEUTICS | 1 | 3 | +1,29 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Halozyme Therapeutics Q4 2025 Earnings Preview | 1 | Seeking Alpha | ||
| Mo | Galapagos NV: Galapagos Receives Transparency Notification from Bank of America | 539 | GlobeNewswire (Europe) | Mechelen, Belgium; February 16, 2026, 22:01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America.
Pursuant to Belgian... ► Artikel lesen | |
| Mo | Why Big Stock Swings Like Medpace's 55% Jump Usually Have Clear Causes--Not Market Madness | 1 | The Motley Fool | ||
| Mo | Kaufsignal bei Biontech: Insider positionieren sich bereits | Hebelschein-Spekulant | |||
| Mo | Spyre Therapeutics (SYRE) Set POC Readout Priorities for 2026 | 3 | Insider Monkey | ||
| Mo | Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) | 4 | Insider Monkey | ||
| Mo | Atacicept's Potential Approval Drives Favorable Views on Vera Therapeutics (VERA) | 1 | Insider Monkey | ||
| Mo | Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA) | 3 | Insider Monkey | ||
| Mo | Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study | 1 | Insider Monkey | ||
| Mo | Here is Why Apogee Therapeutics (APGE) Appears Attractive | 1 | Insider Monkey | ||
| Mo | What Makes BioMarin (BMRN) so Attractive | 2 | Insider Monkey | ||
| Mo | Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough | 2 | Insider Monkey | ||
| Mo | Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE) | 2 | Insider Monkey | ||
| Mo | Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program | 5 | Insider Monkey | ||
| Mo | FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN) | 3 | Insider Monkey | ||
| Mo | Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX) | 1 | Insider Monkey | ||
| Mo | Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry | 1 | Insider Monkey | ||
| Mo | Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating | 1 | Insider Monkey | ||
| Mo | Ascendis Pharma Iberia enters Portugal | 2 | Essential Business | ||
| Mo | Earnings Preview: Halozyme Therapeutics | 3 | Benzinga.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.